About
C4 Therapeutics is a clinical-stage biopharmaceutical company that develops targeted protein degraders to selectively degrade disease-causing proteins previously considered undruggable using the cell's own proteolytic pathways.
Explore C4 Therapeutics Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.